Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 52 of 52 entries
View as:
Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects
Phase: N/A
Priority: Normal
Start: 10/20/24
End: 03/20/25
Due: 03/20/26
Phase: N/A
Priority: Normal
Start: 04/10/25
End: 12/30/25
Due: 12/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects | NCT06653101 | Wecare Probiotics Co., Ltd. | user2@example.com | None | 2024-10-20 | 2025-03-20 | 2026-03-20 | - | - | 2025-07-14 |
| Probiotic LR08 Improves Gut and Metabolism | NCT06875362 | Wecare Probiotics Co., Ltd. | user2@example.com | None | 2025-04-10 | 2025-12-30 | 2026-12-30 | - | - | 2025-07-14 |